NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) YoY EBITDA Growth : -18.97% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. NewAmsterdam Pharma Co NV's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -18.97%.

NewAmsterdam Pharma Co NV's EBITDA per Share for the six months ended in Dec. 2023 was $-1.16.

NewAmsterdam Pharma Co NV YoY EBITDA Growth Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV YoY EBITDA Growth Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-525.93

-132.35

-82.77

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial			-	615.44	-162.80	-242.23	-18.97

NewAmsterdam Pharma Co NV YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

NewAmsterdam Pharma Co NV's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-2.153	-	-1.178)	/	\| -1.178 \|
=	-82.77 %

NewAmsterdam Pharma Co NV's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-1.16	-	-0.975)	/	\| -0.975 \|
=	-18.97 %

NewAmsterdam Pharma Co NV YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (NAS:NAMS) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.